Detail akcie Sandoz Group Rg online

Business Summary: Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Sandoz Group AG revenues increased 4% to $5.27B. Net income increased from $150M to $377M. Revenues reflect Europe segment increase of 8% to $2.83B, International segment increase of 1% to $1.28B. Net income benefited from Other items increase from $5M to $109M (income), Other income - Balancing value increase from $46M to $103M (income).